Annual EBITDA
$5.44B$1.54B+39.32%
Summary
- Current Value
- As of today, BSX annual EBITDA is $5.44B, up +39.32% on
- Historical Performance
- BSX annual EBITDA is up +83.75% over the past 3 years, up +215.67% over the past 5 years
- All-Time High Comparison
- BSX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- BSX annual EBITDA is +83.75% above its 3-year low of $2.96B reached on an earlier date
- Sector Comparison
- BSX annual EBITDA is higher than 97.79% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $5.44B | +39.3% | +83.8% | +215.7% | +187.9% | |
| Quarterly EBITDA | $1.34B | -2.9% | +56.3% | +88.1% | +227.6% | |
| TTM EBITDA | $5.95B | +24.0% | +83.0% | +130.8% | +209.5% | |
| Price | $42.87 | -55.8% | -21.1% | +4.5% | +690.9% | |
| PE Ratio | 18.15 | -65.0% | -72.7% | -67.9% | +23.9% | |
| Annual Revenue | $20.07B | +19.9% | +58.3% | +102.5% | +157.2% | |
| Annual EPS | $1.94 | +55.5% | +334.9% | +2488.1% | +377.0% | |
| Annual EBIT | $3.97B | +50.7% | +117.7% | +560.7% | +270.1% | |
| Annual Net Income | $2.89B | +56.7% | +314.3% | +3626.8% | +371.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.44B | at high | |
| 5Y | $5.44B | at high | |
| All | $5.44B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.96B | N/A | +83.8% |
| 5Y | $1.72B | N/A | +215.7% |
| All | $73.90M | +7259.9% |
EBITDA History
FAQ
- What is the current annual EBITDA of BSX?
- As of today, BSX annual EBITDA is $5.44B
- What is 1-year change in BSX annual EBITDA?
- BSX annual EBITDA is up +39.32% year-over-year
- What is 3-year change in BSX annual EBITDA?
- BSX annual EBITDA is up +83.75% over the past 3 years
- How far is BSX annual EBITDA from its all-time high?
- BSX annual EBITDA is currently at its all-time high
- How does BSX annual EBITDA rank versus sector peers?
- BSX annual EBITDA is higher than 97.79% of companies in Healthcare sector
- When is BSX next annual earnings release?
- The next annual earnings release for BSX is on
EBITDA Formula
Quarterly EBITDA
$1.34B$262.00M-16.32%
Summary
- Current Value
- As of today, BSX quarterly EBITDA is $1.34B, down -16.32% on
- Historical Performance
- BSX quarterly EBITDA is down -2.89% year-over-year, up +56.34% over the past 3 years
- All-Time High Comparison
- BSX quarterly EBITDA is currently -16.32% below its historical high of $1.61B set on
- 3-Year Low Comparison
- BSX quarterly EBITDA is +56.34% above its 3-year low of $859.00M reached on an earlier date
- Sector Comparison
- BSX quarterly EBITDA is higher than 97.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.34B | -16.3% | -2.9% | +56.3% | +88.1% | |
| Annual EBITDA | $5.44B | – | +39.3% | +83.8% | +215.7% | |
| TTM EBITDA | $5.95B | -0.7% | +24.0% | +83.0% | +130.8% | |
| Price | $42.87 | -17.6% | -55.8% | -21.1% | +4.5% | |
| PE Ratio | 18.15 | -13.9% | -65.0% | -72.7% | -67.9% | |
| Quarterly Revenue | $5.14B | -5.6% | +1.4% | +45.7% | +75.2% | |
| Quarterly EPS | $0.40 | -34.8% | -20.6% | +17.1% | +42.1% | |
| Quarterly EBIT | $979.00M | -21.7% | -6.0% | +75.5% | +121.5% | |
| Quarterly Net Income | $580.00M | -35.9% | -23.2% | +15.1% | +38.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.61B | -16.3% | |
| 3Y | $1.61B | -16.3% | |
| 5Y | $1.61B | -16.3% | |
| All | $1.61B | -16.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.34B | at low | |
| 3Y | $859.00M | N/A | +56.3% |
| 5Y | $714.00M | N/A | +88.1% |
| All | -$95.70M | +1503.3% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of BSX?
- As of today, BSX quarterly EBITDA is $1.34B
- What is BSX quarterly EBITDA most recent change?
- BSX quarterly EBITDA was down -16.32% on September 30, 2026
- What is 1-year change in BSX quarterly EBITDA?
- BSX quarterly EBITDA is down -2.89% year-over-year
- How far is BSX quarterly EBITDA from its all-time high?
- BSX quarterly EBITDA is currently -16.32% below its historical high of $1.61B set on June 30, 2026
- How does BSX quarterly EBITDA rank versus sector peers?
- BSX quarterly EBITDA is higher than 97.21% of companies in Healthcare sector
- When is BSX next earnings release?
- The next earnings release for BSX is on
EBITDA Formula
TTM EBITDA
$5.95B$40.00M-0.67%
Summary
- Current Value
- As of today, BSX TTM EBITDA is $5.95B, down -0.67% on
- Historical Performance
- BSX TTM EBITDA is up +24.01% year-over-year, up +83.05% over the past 3 years
- All-Time High Comparison
- BSX TTM EBITDA is currently -0.67% below its historical high of $5.99B set on
- 3-Year Low Comparison
- BSX TTM EBITDA is +83.05% above its 3-year low of $3.25B reached on an earlier date
- Sector Comparison
- BSX TTM EBITDA is higher than 97.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $5.95B | -0.7% | +24.0% | +83.0% | +130.8% | |
| Annual EBITDA | $5.44B | – | +39.3% | +83.8% | +215.7% | |
| Quarterly EBITDA | $1.34B | -16.3% | -2.9% | +56.3% | +88.1% | |
| Price | $42.87 | -17.6% | -55.8% | -21.1% | +4.5% | |
| PE Ratio | 18.15 | -13.9% | -65.0% | -72.7% | -67.9% | |
| TTM Revenue | $21.07B | +0.3% | +8.9% | +53.1% | +83.7% | |
| TTM EPS | $2.36 | -4.2% | +26.3% | +189.3% | +225.1% | |
| TTM EBIT | $4.52B | -1.4% | +31.0% | +117.8% | +203.7% | |
| TTM Net Income | $3.49B | -4.8% | +25.5% | +184.5% | +218.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.99B | -0.7% | |
| 3Y | $5.99B | -0.7% | |
| 5Y | $5.99B | -0.7% | |
| All | $5.99B | -0.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.80B | N/A | +24.0% |
| 3Y | $3.25B | N/A | +83.0% |
| 5Y | $2.58B | N/A | +130.8% |
| All | -$24.90M | >+9999.0% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of BSX?
- As of today, BSX TTM EBITDA is $5.95B
- What is BSX TTM EBITDA most recent change?
- BSX TTM EBITDA was down -0.67% on September 30, 2026
- What is 1-year change in BSX TTM EBITDA?
- BSX TTM EBITDA is up +24.01% year-over-year
- How far is BSX TTM EBITDA from its all-time high?
- BSX TTM EBITDA is currently -0.67% below its historical high of $5.99B set on June 30, 2026
- How does BSX TTM EBITDA rank versus sector peers?
- BSX TTM EBITDA is higher than 97.59% of companies in Healthcare sector
- When is BSX next earnings release?
- The next earnings release for BSX is on
EBITDA Formula
Data Sources & References
- BSX Official Website www.bostonscientific.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/885725/000088572526000010/0000885725-26-000010-index.htm
- BSX Profile on Yahoo Finance finance.yahoo.com/quote/BSX
- BSX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bsx
